Differential autonomic nervous system response in obese and anorexic chickens (Gallus gallus).
Effect of reserpine on body weight (BW), feed intake (FI), brain and plasma catecholamine and indoleamine concentrations in high- (HWS) and low- (LWS) weight selected lines of chickens was investigated. Chicks from each line were assigned to three treatment groups and injected intraperitoneally with 0, 1.25, or 2.50 mg/kg of reserpine at hatch, and again at 5 weeks-of-age. Chick BW and FI were determined weekly. At 7 weeks-of-age, 12 males and females from each group were sacrificed for neurotransmitter analysis. In the HWS line there was a dose-dependent decrease in BW through 7 weeks-of-age, whereas in the LWS line BW decreased only through the first 2 weeks-of-age. In the LWS line, norepinephrine (NE), epinephrine, and 3,4-dihydroxyphenylacetate concentrations decreased in the brain in a linear and quadratic manner in response to reserpine, but not in the HWS line. Both lines showed linear decreases in dopamine levels in response to reserpine; however, serotonin was not affected by reserpine. Chickens in the HWS line had greater plasma NE, and lower 5-hydroxyindoleacetic acid than those in the LWS line. In conclusion, it appears that chickens from the HWS line were more sensitive to the BW reducing effects of reserpine than those from the LWS line, with the latter appearing to have greater sympathetic nervous system activity.
Kuo
Alice Y
AY
Department of Animal and Poultry Sciences, 0306, Virginia Polytechnic Institute and State University, Blacksburg, 24061, USA.
Lee
John C
JC
Magnin
Geraldine
G
Siegel
P B
PB
Denbow
D Michael
DM
D000821:Animal Feed; D000818:Animals; D000855:Anorexia / Q000097:blood; D001341:Autonomic Nervous System / Q000187:drug effects*; D001835:Body Weight; D001921:Brain / Q000187:drug effects; D002395:Catecholamines / Q000097:blood; D002645:Chickens / Q000097:blood / Q000502:physiology*; D004435:Eating / Q000187:drug effects; D007211:Indoles / Q000097:blood; D009765:Obesity / Q000097:blood; D012110:Reserpine / Q000494:pharmacology*; D016896:Treatment Outcome
D002395:Catecholamines; D007211:Indoles; D012110:Reserpine